YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Cadila Healthcare

Cadila Healthcare

BSE: 532321|NSE: CADILAHC|ISIN: INE010B01027|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 27, 12:10
449.05
26.7 (6.32%)
VOLUME 576,032
LIVE
NSE
Nov 27, 12:11
449.25
26.95 (6.38%)
VOLUME 11,795,158
News on Cadila Healthcare
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Cadila Healthcare shares up 3% on plans to launch COVID-19 vaccine by March 2021

9.34 am | 27 Nov 2020 |  Source: Moneycontrol.com

Zydus Cadila said it will apply for Phase 3 clinical trials of its experimental COVID-19 vaccine in December, and expects to launch it by March 2021....

HCL Tech, Sun Pharma among 10 largecap names that can give 8-30% returns in a year

1.57 pm | 19 Nov 2020 |  Source: Moneycontrol.com

Analysts and brokerage firms are bullish on market prospects as events such as the US election is over and positive reports on the vaccine front are g...

COVID-19 Vaccine Tracker: Here's a status update on leading coronavirus vaccines that are ahead of the pack

4.27 pm | 13 Nov 2020 |  Source: Moneycontrol.com

COVID-19 Vaccine Tracker: Pfizer's first interim data, which suggested the vaccine is 90 percent effective, has raised the hopes of possible Covid...

Cadila Healthcare shares up 4% on completion of phase-II trial of COVID vaccine

11.47 am | 12 Nov 2020 |  Source: Moneycontrol.com

Based upon the results from its Phase 2 study, Zydus Cadila now plans to conduct a Phase 3 clinical trial in India....

Accumulate Cadila Healthcare; target of Rs 497: Dolat Capital Market

6.54 pm | 07 Nov 2020 |  Source: Moneycontrol.com

Dolat Capital Market recommended accumulate rating on Cadila Healthcare with a target price of Rs 497 in its research report dated November 02, 2020....

Buy Cadila Healthcare; target of Rs 555: ICICI Direct

1.41 pm | 07 Nov 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 555 in its research report dated Novemb...

Sell Cadila Healthcare; target of Rs 357: Prabhudas Lilladher

4.45 pm | 06 Nov 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bearish on Cadila Healthcare has recommended sell rating on the stock with a target price of Rs 357 in its research report date...

Buy Cadila Healthcare: target of Rs 530: Sharekhan

5.07 pm | 05 Nov 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Cadila Healthcare recommended buy rating on the stock with a target price of Rs 530 in its research report dated November 03, ...

Covid Vaccine: Zydus Cadila completes phase-2 trial, to submit data in November

1.24 pm | 03 Nov 2020 |  Source: Moneycontrol.com

MD Sharvil Patel says company plans to begin phase-3 in December, upon approval, and expects to have final data by March-April 2021. The company plans...

Cadila Healthcare shares hit 52-week high as Q2 profit jumps 4-fold

12.04 pm | 03 Nov 2020 |  Source: Moneycontrol.com

CLSA has maintained buy call on the stock and has raised target to Rs 540 from Rs 525 per share...

Cadila Health Standalone September 2020 Net Sales at Rs 2,056.90 crore, up 22.24% Y-o-Y

9.22 am | 03 Nov 2020 |  Source: Moneycontrol.com

NULL...

Cadila Health Consolidated September 2020 Net Sales at Rs 3,820.00 crore, up 13.47% Y-o-Y

9.11 am | 03 Nov 2020 |  Source: Moneycontrol.com

NULL...

Cadila Healthcare Q2 net profit jumps over four-fold to Rs 473.4 crore

7.49 pm | 02 Nov 2020 |  Source: PTI

The company had posted a net profit of Rs 107.2 crore for the corresponding period of the previous financial year, Cadila Healthcare said in a BSE fil...

Cadila Healthcare share price rises 2% post USFDA approval

12.00 pm | 23 Oct 2020 |  Source: Moneycontrol.com

The drug will be manufactured at the group’s formulation manufacturing facility at the SEZ, Ahmedabad....

Traders can opt for buy-on-dip strategy till Nifty trades above 11,500

11.58 am | 19 Oct 2020 |  Source: Moneycontrol.com

The index has given bullish crossover as 100 DMA crossed 200 DMA from below, signaling that the strong bullish momentum will continue in the mid term....

Cadila: a formidable play in Covid times and beyond

9.39 am | 25 Sep 2020 |  Source: Moneycontrol.com

Cadila is not only a credible Indian pharma striving for a Covid solution, but on a longer time scale is an interesting watch in the large-cap space w...

Reduce Cadila Healthcare; target of Rs 408: Dolat Capital

5.05 pm | 17 Aug 2020 |  Source: Moneycontrol.com

Dolat Capital recommended reduce rating on Cadila Healthcare with a target price of Rs 408 in its research report dated August 14, 2020....

Buy Cadila Healthcare; target of Rs 470: ICICI Direct

1.00 pm | 10 Aug 2020 |  Source: Moneycontrol.com

ICICI Direct is bullish on Cadila Healthcare has recommended buy rating on the stock with a target price of Rs 470 in its research report dated August...

Accumulate Cadila Healthcare; target of Rs 408: Dolat Capital

9.16 pm | 09 Aug 2020 |  Source: Moneycontrol.com

Dolat Capital recommended accumulate rating on Cadila Healthcare with a target price of Rs 408 in its research report dated August 05, 2020....

Hold Cadila Healthcare; target of Rs 402: Emkay Global Financial

2.43 pm | 08 Aug 2020 |  Source: Moneycontrol.com

Emkay Global Financial recommended hold rating on Cadila Healthcare with a target price of Rs 402 in its research report dated August 05, 2020....

1 2 3
Quick Links for Cadila Healthcare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.